LSGPA INVESTS $250,000 IN MICRO INTERVENTIONAL DEVICES, INC.
Medical Device Developer Striving to
Make Cardiac Surgery
Faster, Safer and Less Costly
Bethlehem, PA – March
1, 2012. The Life Sciences
Greenhouse of Central Pennsylvania (LSGPA) announced today an investment of $250,000
in Micro Interventional Devices, Inc. (MID), a developer of structural heart
repair technologies.
MID’s initial product offering is a minimally invasive
device known as Permaseal™, which provides access and wound closure during
structural heart repair procedures. Designed
to move with the beating heart while still keeping the edges of the wound
closed, the Permaseal device not only enables wound healing without the use of
sutures, it is cost- and time-efficient.
“The Permaseal access and closure device will enable
unprecedented safe and reliable transmyocardial access for structural heart
repair procedures,” says Michael Whitman, President & CEO. “It is our hope that Permaseal becomes the
new standard of care for access and closure for these procedures.”
The patent pending Permaseal technology allows the surgeon
to remotely affix a biocompatible implant to the apex of the heart, creating an
“access site” on the myocardial surface of the heart. This provides sutureless
access for a wide range of structural heart repair procedures including transcatheter
aortic valve implantation (TAVI), transcatheter mitral valve replacement,
mitral valve repair and other emerging structural heart repair procedures.
No comments:
Post a Comment